Group One Trading, L.P. Acurx Pharmaceuticals, Inc. Transaction History
Group One Trading, L.P.
- $2.68 Billion
- Q2 2025
A detailed history of Group One Trading, L.P. transactions in Acurx Pharmaceuticals, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 13,607 shares of ACXP stock, worth $110,216. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,607
Previous 1,165
1067.98%
Holding current value
$110,216
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ACXP
# of Institutions
37Shares Held
2.71MCall Options Held
62.9KPut Options Held
56.9K-
Armistice Capital, LLC New York, NY1.08MShares$8.74 Million0.01% of portfolio
-
Prospect Financial Services LLC Melville, NY367KShares$2.97 Million0.08% of portfolio
-
Geode Capital Management, LLC Boston, MA146KShares$1.19 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA146KShares$1.18 Million0.0% of portfolio
-
Morgan Stanley New York, NY106KShares$860,2280.0% of portfolio
About Acurx Pharmaceuticals, Inc.
- Ticker ACXP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,556,600
- Market Cap $93.6M
- Description
- Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The com...